dihexa half-life 12 days Drug Half Life - an overview Synapse (Dihexa) Cognitive Peptide Therapy

Body Protecting Compound 157 (BPC-157 ) is a synthetic peptide derived from a sequence found in human gastric juice

Our patients who have transferred from relative stability on less frequent injection protocols have all, without exception, noted a qualitative difference in their sense of wellbeing now that they are microdosing and would not choose to go back to their previous injection regimen

The peptide supports but does not replace fundamental healing requirements like appropriate rest, physical therapy, and proper nutrition

Depending on your specific needs, our providers may recommend subcutaneous injections, oral capsules, or nasal sprays

The standard cagrilintide monotherapy titration follows this schedule: 0.25 mg weekly for weeks 1-4, then 0.5 mg for weeks 5-8, then 1.0 mg for weeks 9-12, then 1.7 mg for weeks 13-16, and finally 2.4 mg for week 17 onward as the maintenance dose